Location History:
- Starogard Gdanski, PL (2013)
- Gniew, PL (2017)
Company Filing History:
Years Active: 2013-2017
Title: Innovator Spotlight: Roman Szramka
Introduction: Roman Szramka, based in Gniew, Poland, is a notable inventor recognized for his contributions to the pharmaceutical industry. He has secured two patents that reflect his innovative approaches in drug synthesis, demonstrating his commitment to advancing medical therapies.
Latest Patents: Szramka's most recent patents include a sophisticated method for manufacturing vardenafil and its salts. This innovative process involves synthesizing the vardenafil base under anhydrous conditions through chlorosulfonation, which is followed by amidation. Additionally, he has developed a method for converting the vardenafil base into vardenafil monohydrochloride trihydrate, achieving a melting point of 234°C. Another significant patent involves the preparation of [1-hydroxy-2-(1-imidazol-1-yl)-ethylidene]bisphosphonic acid, through a well-structured series of chemical reactions, resulting in a monohydrate form of the compound.
Career Highlights: Szramka has made substantial contributions working at Zakłady Farmaceutyczne Polpharma S.A., where his expertise in pharmaceutical chemistry and process development has played a crucial role in the company's innovations. His work not only highlights his skills as an inventor but also his dedication to enhancing drug manufacturing techniques.
Collaborations: Throughout his career, Roman Szramka has collaborated with esteemed colleagues such as Robert Rynkiewicz and Jerzy Drygas. Their collective expertise in the field has likely contributed to the success of his patents and innovations, fostering an environment of creative problem-solving and scientific advancement.
Conclusion: Roman Szramka exemplifies the spirit of innovation in the pharmaceutical sector. His patents reflect groundbreaking methods that hold the potential to influence drug development and manufacturing. As he continues to work at Zakłady Farmaceutyczne Polpharma S.A. and collaborate with talented individuals, Szramka's future contributions are eagerly anticipated in the world of pharmaceuticals.